This article highlights the latest guidance on appropriate dosing of direct-acting oral anticoagulants (DOACs) in people with non-valvular atrial fibrillation (NVAF). Key considerations include specific dose adjustment requirements for each DOAC and the importance of improving patient adherence with DOAC therapy.
Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease.
This article describes a new best practice framework service specification which is available to download free from Anticoagulation UK. The specification has been designed to support services to deliver best practice in anticoagulation diagnosis and management during and beyond the current pandemic.